WO2025163465 - METHOD AND SYSTEM FOR MERGING BIO-ELECTROSPRAYING, CELL ELECTROSPINNING MERGED WITH 3D MULTIMATERIAL MICROFLUIDIC BIOPRINTING FABRICATE HUMAN TISSUES FOR DRUG DISCOVERY APPLICATIONS

National phase entry is expected:
Publication Number WO/2025/163465
Publication Date 07.08.2025
International Application No. PCT/IB2025/050877
International Filing Date 27.01.2025
Title **
[English] METHOD AND SYSTEM FOR MERGING BIO-ELECTROSPRAYING, CELL ELECTROSPINNING MERGED WITH 3D MULTIMATERIAL MICROFLUIDIC BIOPRINTING FABRICATE HUMAN TISSUES FOR DRUG DISCOVERY APPLICATIONS
[French] PROCÉDÉ ET SYSTÈME DE FUSION DE BIO-ÉLECTROPULVÉRISATION, ÉLECTROFILAGE CELLULAIRE FUSIONNÉ AVEC UNE BIO-IMPRESSION MICROFLUIDIQUE MULTIMATÉRIAU 3D FABRIQUANT DES TISSUS HUMAINS POUR DES APPLICATIONS DE DÉCOUVERTE DE MÉDICAMENT
Applicants **
OUROBIONICS BV
Inventors
JAYASINGHE, Suwan N.
GRAY, Stephen G.
LEYLAVI SHOUSHTARI, Ali
Priority Data
18/424,913   29.01.2024   US
Application details
Total Number of Claims/PCT *
Number of Independent Claims *
Number of Priorities *
Number of Multi-Dependent Claims *
Number of Drawings *
Pages for Publication *
Number of Pages with Drawings *
Pages of Specification *
*
Number of Office Actions *
*
International Searching Authority
*
Recordal of a Change of the Applicant's Name/Address
*
Type of Assignment
*
Applicant's Legal Status
*
*
*
*
*
*
Entry into National Phase under
*
Patent Delivery
*
Translation

* The data is based on automatic recognition. Please verify and amend if necessary.

** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.

Quotation for National Phase entry

Country StagesTotal
China Filing, Examination, Granting2171
EPO Filing, Examination, Granting10656
Japan Filing, Examination, Granting2307
South Korea Filing, Examination, Granting2380
USA Filing, Examination, Granting4740
MasterCard Visa
Total: 22,254
Contact Us
Abstract[English] The present invention provides a method and system for fabricating complex human tissues by integrating bio-electrospraying, cell electrospinning merged with 3D multi material microfluidic bioprinting, and future additions of magnetic and acoustic levitation technologies. The fabricated tissues serve as an alternative to animal testing in drug discovery processes, aiding in the prediction of human physiological responses to various drug compounds.[French] La présente invention concerne un procédé et un système de fabrication de tissus humains complexes par intégration d'une bio-électropulvérisation, d'un électrofilage cellulaire fusionné avec une bio-impression microfluidique multi-matériaux 3D et d'additions futures de technologies de lévitation magnétique et acoustique. Les tissus fabriqués servent d'alternative à l'essai animal dans des processus de découverte de médicament, aidant à la prédiction de réponses physiologiques humaines à divers composés médicamenteux.